Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating restricted access to the CRETA trial details on ClinicalTrials.gov. This reflects an access issue rather than a substantive update to the study information.
    Difference
    20%
    Check dated 2026-09-19T19:18:13.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page revision updated the version from v3.6.5 to v3.6.6, signaling a minor update to the record. No substantive changes to the study details are indicated.
    Difference
    0.0%
    Check dated 2026-08-29T18:29:08.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous v3.6.4, indicating a small update to the page template or content management system.
    Difference
    0.0%
    Check dated 2026-08-08T09:37:19.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.4, replacing the previous v3.6.3. This indicates a maintenance update to the page rather than a change to study data or functionality.
    Difference
    0.0%
    Check dated 2026-07-25T06:22:42.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page's Revision tag has been updated to v3.6.3, replacing the previous v3.6.2. This indicates a minor maintenance update to the site version tag.
    Difference
    0.0%
    Check dated 2026-07-03T22:03:20.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The revision line on the page was updated from Revision: v3.6.0 to Revision: v3.6.2. This indicates a newer version of the page content.
    Difference
    0.0%
    Check dated 2026-06-27T02:04:37.000Z thumbnail image

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.